病例报告:在缺乏葡萄糖-6-酸盐脱酶的患者中,甲胺诱导的溶血性贫血
Alaa M Salamat1, Hani M Ammar2, Ahmed I Alsagheir3
1Department of Internal Medicine, Johns Hopkins Aramco Healthcare, Saudi Arabia.
The Journal of international medical research
|October 28, 2025
概括
甲福明治疗可能会在患有葡萄糖-6-酸盐脱酶缺乏症的患者中引发血清性贫血. 这一案例凸显了在为2型糖尿病开设甲型素之前考虑G6PD状态的重要性.
科学领域:
- 内部医学 内部医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖-6-酸盐脱酶 (G6PD) 缺乏症是一种常见的遗传性红细胞疾病.
- 2型糖尿病 (T2DM) 是一种普遍的代谢状况,需要药理管理.
- 甲胺是一种一线抗糖尿病药物,具有普遍有利的安全性.
研究的目的:
- 在G6PD缺乏症患者中报告甲福林诱导的血液溶解性贫血病例.
- 为了突出潜在的药物诱导的血溶性贫血风险与敏感个体的甲福明相关.
- 强调在开始甲福林治疗之前对G6PD缺乏症进行查的重要性.
主要方法:
- 案例报告的呈现方式.
- 审查患者的病史,包括诊断T2DM和G6PD缺乏.
- 临床和实验室评估甲福尔开始后的溶血性贫血.
主要成果:
- 一名60多岁的男性患者患有已知的G6PD缺乏症,患有严重的溶血性贫血.
- 贫血的发作与新诊断的T2DM的甲福明开始暂时相关.
- 终止了甲胺,导致了血液溶解性贫血的解决.
结论:
- 在G6PD缺乏症患者中,甲福明可以导致临床显著的血液溶解性贫血.
- 医生应谨慎行事,并考虑在风险患者中进行G6PD测试,然后再开药.
- 这一案例强调了一种罕见但严重的药物不良反应,这种不良反应可能发生在甲福明治疗中.
相关概念视频
Glucose Transporters
15.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.3K
Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
998
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
998
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hypoglycemia
34
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
34
Hyperglycemia
34
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
34


